Compounds, composition, methods, targets for cancer therapy
US8680129B2 · kind B2 · utility
1Cited by
0References
1Claims
0Family size
Inventor
Key dates
| Filing date | Jan 4, 2010 |
| Grant date | Mar 25, 2014 |
| Priority date | — |
| Expiry date | Feb 1, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention describes methods and pharmaceutical compositions for combinational cancer treatments that are capable of inducing JNK phosphorylation and induce programmed cell death. It also identified genes as target for anti-cancer drug development and enhancement of the chemotherapeutic drug effect for the treatment of cancer. This invention points to a novel method and principle for a new avenue of developing more efficient and low or non cytotoxic cancer treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.